STOCK TITAN

[SCHEDULE 13G/A] BAXTER INTERNATIONAL INC Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 11 to a Schedule 13G/A reporting that it beneficially owns 0 shares of Baxter International Inc. common stock, representing 0% of the class after an internal realignment. The filing states certain Vanguard subsidiaries will report ownership separately in accordance with SEC Release No. 34-39538, effective with the reorganization described, and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries. The amendment is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Amendment reflects administrative disaggregation, not an economic sale.

The filing documents an internal reorganization within The Vanguard Group that causes certain subsidiaries to report beneficial ownership separately under SEC Release No. 34-39538. The Vanguard Group reports 0 shares and 0% ownership in Baxter following that realignment.

Cash‑flow treatment and any trading activity by the separated subsidiaries are not described in the excerpt; subsequent filings by the individual subsidiaries would show their reported positions if any.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What did The Vanguard Group report for BAX in Amendment No. 11?

The filing reports 0 shares beneficially owned and 0% of Baxter International common stock. It attributes the change to an internal realignment and separate reporting by Vanguard subsidiaries under SEC Release No. 34-39538.

Why does Vanguard report zero ownership of Baxter (BAX)?

Vanguard states an internal realignment led certain subsidiaries to report beneficial ownership separately. Under SEC Release No. 34-39538, The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries.

Does this filing show any purchases or sales of BAX by Vanguard?

No. The amendment records beneficial ownership as 0 shares and describes organizational reporting changes. It does not disclose any purchase, sale, or cash proceeds related to Baxter common stock in the provided excerpt.

When did Vanguard sign the Schedule 13G/A amendment for Baxter?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/26/2026. The cover lists 03/13/2026 as an associated filing date.

Will other Vanguard entities report Baxter holdings separately now?

Yes. The filing states certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538, pursuing the same investment strategies as before the realignment.
Baxter Intl Inc

NYSE:BAX

View BAX Stock Overview

BAX Rankings

BAX Latest News

BAX Latest SEC Filings

BAX Stock Data

8.24B
512.45M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
DEERFIELD